Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Rosuvastatin for Inflammatory Biomarkers in Acute Coronary Syndrome
NCT06053983Phase 4Completed
- Sponsor
- Rawalpindi Medical University
- Start
- Jan 2023
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, rosuvastatin in acute coronary syndrome (ACS), sponsored by Rawalpindi Medical University. Started Jan 2023; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06053983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06053983.